<DOC>
	<DOC>NCT01967953</DOC>
	<brief_summary>The recent introduction of ex-vivo lung perfusion (EVLP) as a tool to evaluate and recondition lungs from marginal donors has opened a new era in the field of lung transplantation.</brief_summary>
	<brief_title>Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation</brief_title>
	<detailed_description>Aim of the investigation: to compare the clinical outcome after transplantation of subjects receiving marginal lungs procured from brain death donors and reconditioned by EVLP, with that of subjects receiving lungs procured from standard donors.</detailed_description>
	<mesh_term>Brain Death</mesh_term>
	<mesh_term>Primary Graft Dysfunction</mesh_term>
	<criteria>Inclusion criteria for donor lung: 1. Recipient to undergo single or bilateral Lung Transplantation 2. Donor arterial partial pressure of oxygen to fraction of inspired oxygen ratio (PaO2/FiO2) below 300 mmHg, or doubtful donor lung function Exclusion criteria for donor lung: 1. Massive lung contusion 2. Aspiration 3. Pneumonia 4. Sepsis 5. Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>